ScholarWorks@Dongguk University

Browsing by Kim, MisoAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 4 of 4

SCIESCOPUSKCI
2020 Korean guidelines for the management of metastatic prostate canceropen access

Kim, In-Ho; Shin, Sang Joon; Kang, Byung Woog; Kang, Jihoon; Kim, Dalyong; Kim, Miso; Kim, Jin Young; Kim, Chan Kyu; Kim, Hee-Jun; Maeng, Chi Hoon, et al.

ArticleIssue Date2021CitationKOREAN JOURNAL OF INTERNAL MEDICINE, v.36, no.3, pp 491 - 514PublisherKOREAN ASSOC INTERNAL MEDICINE
SCIESCOPUSKCI
Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patientsopen access

Choi, Yeonjoo; Keam, Bhumsuk; Kim, Miso; Yoon, Shinkyo; Kim, Dalyong; Choi, Jong Gwon; Seo, Ja Young; Park, Inkeun; Lee, Jae Lyun

ArticleIssue Date2019CitationCANCER RESEARCH AND TREATMENT, v.51, no.4, pp 1549 - 1556PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trialopen access

Kim, Yongjoo; Yeom, Chan-Woo; Lee, Hyun Jeong; Kim, Jeong-Hyun; Lee, Kwang-Min; Kim, Tae-Yong; Lee, Han-Byoel; Kim, Hoon; Im, Seock-Ah; Lee, Kyung-Hun, et al.

ArticleIssue Date2024Citationnpj Breast Cancer, v.10, no.1, pp 1 - 8PublisherNature Publishing Group | Breast Cancer Research Foundation
SCIESCOPUS
LM-CLIP: Adapting Positive Asymmetric Loss for Long-Tailed Multi-Label Classificationopen access

Timmermann, Christoph; Jung, Seunghyeon; Kim, Miso; Lee, Woojin

ArticleIssue Date2025CitationIEEE Access, v.13, pp 71053 - 71065PublisherIEEE
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114

Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어